drugset / Trial / NCT05249634
Testosterone Treatment in Men With Chronic Kidney Disease
NaSingle-groupOpen-labelTreatment
Summary
This study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).
Timeline
- Start
- 2022-03-15
- Primary completion
- 2028-06
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone Undecanoate | Small molecule | — | Oral |